Instead of turning to a one-size-fits-all solution, we should look to proven models for Federal programs, such as Medicare Advantage.

I want to make it very clear. The Republicans are asking for negotiations on the debt ceiling process, to add some fiscal restraint into the debt ceiling extension.

I thank the Biden administration who worked very closely with us.

this administration has taken unprecedented steps to erode this pathway, deterring lifesaving innovation and delaying access to care.

We are not talking about trying to reduce benefits in Medicare or Social Security for our seniors.

I want to make it clear. We are not talking about trying to reduce benefits in Medicare or Social Security for our seniors.

Judge Brailsford represents the best our State has to offer, and I hope you'll be able to support her nomination in this process.

This unbalanced approach does nothing to address Medicare's cost drivers.

Without further action, however, these policies will expire at the end of 2024, creating a coverage cliff for tens of millions of seniors across the country.

I encourage you to look at this carefully, and if you have not already done it, to conduct an impact analysis.

Government price mandates, however, are a step in the wrong direction.

We are fortunate that in America we are coming up with new, innovative treatments, and we are doing everything we can to accelerate them.

I would just encourage all of my colleagues in the Senate, but particularly the President, to engage with us in those kinds of negotiations.

I thank the Biden administration who worked very closely with us.

I ask you, Secretary Becerra, to take back to the President my plea that he engage with us in negotiations.

We are fortunate that in America we are coming up with new, innovative treatments, and we are doing everything we can to accelerate them.

Well, thank you. And encourage us as strongly as you can to get that legislatively done.

Government price mandates, however, are a step in the wrong direction.

We will look for every innovative approach, every pathway possible to make sure that, one, we can put a safe and effective drug in front of the American people.

Instead of turning to a one-size-fits-all solution, we should look to proven models for Federal programs, such as Medicare Advantage.

We are fortunate that in America we are coming up with new, innovative treatments, and we are doing everything we can to accelerate them.

The Federal Government should focus on supporting States as they work to return Medicaid to post-pandemic normalcy.

Without further action, however, these policies will expire at the end of 2024, creating a coverage cliff for tens of millions of seniors across the country.

I want to make it clear. We are not talking about trying to reduce benefits in Medicare or Social Security for our seniors.

I encourage you to look at this carefully, and if you have not already done it, to conduct an impact analysis.